Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RLMD
RLMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RLMD News
Relmada Therapeutics Stock Rises After Piper Sandler Coverage Launch
6d ago
seekingalpha
Relmada Reports 2025 Financials and Clinical Advancements
Mar 20 2026
NASDAQ.COM
Relmada Therapeutics Financial Report Analysis
Mar 20 2026
Yahoo Finance
Relmada (RLMD) Q4 2025 Earnings Call Transcript
Mar 20 2026
NASDAQ.COM
Relmada Therapeutics Q4 Earnings Call Highlights
Mar 19 2026
Yahoo Finance
Relmada Therapeutics Q4 Earnings Report Analysis
Mar 19 2026
seekingalpha
Xenon and Relmada Surge on Positive Drug Data
Mar 09 2026
Yahoo Finance
Relmada Therapeutics to Participate in Healthcare Conference
Mar 09 2026
Newsfilter
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
Mar 09 2026
Benzinga
Relmada Therapeutics Reports Promising Interim Data for Bladder Cancer Treatment
Mar 09 2026
Benzinga
Relmada's Bladder Cancer Treatment Shows Promising Phase 2 Trial Results
Mar 09 2026
stocktwits
Relmada Secures $160 Million in PIPE Financing
Mar 09 2026
Newsfilter
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
Feb 26 2026
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
Feb 26 2026
Newsfilter
BTIG Initiates Buy Rating on Invivyd Inc with $10 Price Target
Dec 22 2025
Benzinga
Relmada Therapeutics Sets Price for $100 Million Underwritten Common Stock and Pre-Funded Warrant Offering
Nov 04 2025
Newsfilter
Show More News
